MET-EGFR dimerization in lung adenocarcinoma is dependent on EGFR mtations and altered by MET kinase inhibition

Advanced lung cancer has poor survival with few therapies. EGFR tyrosine kinase inhibitors (TKIs) have high response rates in patients with activating EGFR mutations, but acquired resistance is inevitable. Acquisition of the EGFR T790M mutation causes over 50% of resistance; MET amplification is als...

Descripción completa

Detalles Bibliográficos
Autores principales: Ortiz-Zapater, Elena, Lee, Richard W., Owen, William, Weitsman, Gregory, Fruhwirth, Gilbert, Dunn, Robert G., Neat, Michael J., McCaughan, Frank, Parker, Peter, Ng, Tony, Santis, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5283661/
https://www.ncbi.nlm.nih.gov/pubmed/28141869
http://dx.doi.org/10.1371/journal.pone.0170798

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5283661/
https://www.ncbi.nlm.nih.gov/pubmed/28141869
http://dx.doi.org/10.1371/journal.pone.0170798

Ejemplares similares